Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Exercise prescription plus the use of a wearable fitness tracker vs exercise prescription alone Adherence to exercise training (long term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Wearable fitness tracker plus text message for personalized feedback and goal setting vs wearable fitness tracker alone Time to subsequent pulmonary exacerbation (medium term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Wearable fitness tracker plus text message for personalized feedback and goal setting vs wearable fitness tracker alone Usability of digital health technology (medium term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Wearable fitness tracker plus text message for personalized feedback and goal setting vs wearable fitness tracker alone QoL (long term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Wearable fitness tracker plus text message for personalized feedback and goal setting vs wearable fitness tracker alone Exercise capacity (long term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based application to record, monitor and set goals on physical activity plus usual care vs usual care alone Adherence to exercise training (long term) · adolescents and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based application to record, monitor and set goals on physical activity plus usual care vs usual care alone Self‐management behavior (long term) · adolescents and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based application to record, monitor and set goals on physical activity plus usual care vs usual care alone Usability of digital health technology (medium term) · adolescents and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based application to record, monitor and set goals on physical activity plus usual care vs usual care alone QoL (long term) · adolescents and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Exercise prescription plus the use of a wearable fitness tracker vs exercise prescription alone Self‐management behavior (long term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based application to record, monitor and set goals on physical activity plus usual care vs usual care alone Exercise capacity (long term) · adolescents and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based vs face‐to‐face exercise delivery Adherence to exercise training (long term) · children and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based vs face‐to‐face exercise delivery Self‐management behavior (long term) · children and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based vs face‐to‐face exercise delivery Time to subsequent pulmonary exacerbation (medium term) · children and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based vs face‐to‐face exercise delivery Usability of digital health technology (medium term) · children and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based vs face‐to‐face exercise delivery QoL: CFQ‐R scores (long term) · children and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based vs face‐to‐face exercise delivery Exercise capacity · children and adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Exercise prescription plus the use of a wearable fitness tracker vs exercise prescription alone Time to subsequent pulmonary exacerbation (medium term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Exercise prescription plus the use of a wearable fitness tracker vs exercise prescription alone Usability of digital health technology (medium term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Exercise prescription plus the use of a wearable fitness tracker vs exercise prescription alone QoL: CFQ‐R scores (long term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Exercise prescription plus the use of a wearable fitness tracker vs exercise prescription alone Exercise capacity – submaximal GXT (long term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Wearable fitness tracker plus text message for personalized feedback and goal setting vs wearable fitness tracker alone Adherence to exercise training (long term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Wearable fitness tracker plus text message for personalized feedback and goal setting vs wearable fitness tracker alone Self‐management behavior (long term) · adults with CF Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis (2023) · Cochrane | no estimate extracted | NR | No studies |
CBT interventions (CBT with and without exercise) vs control (standard care or sham treatments) Adverse effects · older adults (mean age minus 1 standard deviation is more than 60 years) Cognitive behavioural therapy (CBT) with and without exercise to reduce fear of falling in older people… (2023) · Cochrane | no estimate extracted | NR | No studies |
Normothermic machine perfusion (NMP) vs static cold storage (SCS) Quality of life ‐ not measured · liver transplant recipients Machine perfusion in liver transplantation (2023) · Cochrane | no estimate extracted | NR | No studies |
Hypothermic oxygenated perfusion (HOPE) vs static cold storage (SCS) Quality of life ‐ not measured · liver transplant recipients Machine perfusion in liver transplantation (2023) · Cochrane | no estimate extracted | NR | No studies |
Community‐based growth monitoring and promotion (no supplementary feeding) vs standard care Mean weight‐for‐age z‐score · and The impact of growth monitoring and promotion on health indicators in children under five years of age in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Community‐based growth monitoring and promotion (no supplementary feeding) vs standard care Mean height‐for‐age z‐score · and The impact of growth monitoring and promotion on health indicators in children under five years of age in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Community‐based growth monitoring and promotion (no supplementary feeding) vs standard care Infant and child feeding practices · and The impact of growth monitoring and promotion on health indicators in children under five years of age in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Community‐based growth monitoring and promotion (no supplementary feeding) vs standard care Health service usage · and The impact of growth monitoring and promotion on health indicators in children under five years of age in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Community‐based growth monitoring and promotion (with supplementary feeding) vs standard care Health service usage · and The impact of growth monitoring and promotion on health indicators in children under five years of age in… (2023) · Cochrane | no estimate extracted | NR | No studies |
GnRHas vs no treatment No studies included for any outcomes · Women with endometriosis Gonadotropin‐releasing hormone analogues for endometriosis (2023) · Cochrane | no estimate extracted | NR | No studies |
GnRHas vs intra‐uterine progestogens device No studies included with only low risk of bias · Women with pain due to endometriosis Gonadotropin‐releasing hormone analogues for endometriosis (2023) · Cochrane | no estimate extracted | NR | No studies |
GnRHas vs analgesics No studies included for any outcomes · Women with pain due to endometriosis Gonadotropin‐releasing hormone analogues for endometriosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Silicone hydrogel vs hydrogel soft contact lenses Mean change in patient‐reported comfort score from baseline using CLDEQ‐8 · adults with refractive errors Silicone hydrogel versus hydrogel soft contact lenses for differences in patient‐reported eye comfort and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Electrical or magnetic stimulation vs no treatment, sham treatment or verbal/written instruction Objective cure or improvement: > 6 to 12 months · men with urinary incontinence following prostate surgery Conservative interventions for managing urinary incontinence after prostate surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Electrical or magnetic stimulation vs no treatment, sham treatment or verbal/written instruction Participant adherence to the intervention: as reported by the trialists, > 6 to 12 months · men with urinary incontinence following prostate surgery Conservative interventions for managing urinary incontinence after prostate surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Electrical or magnetic stimulation vs no treatment, sham treatment or verbal/written instruction General quality of life: > 6 to 12 months · men with urinary incontinence following prostate surgery Conservative interventions for managing urinary incontinence after prostate surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Electrical or magnetic stimulation vs no treatment, sham treatment or verbal/written instruction Number of participants experiencing surface or skin‐related adverse events: e.g. skin reactions, bruising, hypersensitivity to gel · men with urinary incontinence following prostate surgery Conservative interventions for managing urinary incontinence after prostate surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Electrical or magnetic stimulation vs no treatment, sham treatment or verbal/written instruction Number of participants experiencing muscle‐related adverse events: e.g. soreness, discomfort, cramps, pain · men with urinary incontinence following prostate surgery Conservative interventions for managing urinary incontinence after prostate surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Pelvic floor muscle training (PFMT) plus biofeedback vs no treatment, sham treatment or verbal/written instruction Condition‐specific quality of life: using validated questionnaires, > 6 to 12 months · men with urinary incontinence following prostate surgery Conservative interventions for managing urinary incontinence after prostate surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Pelvic floor muscle training (PFMT) plus biofeedback vs no treatment, sham treatment or verbal/written instruction Participant adherence to the intervention: as reported by the trialists, > 6 to 12 months · men with urinary incontinence following prostate surgery Conservative interventions for managing urinary incontinence after prostate surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Pelvic floor muscle training (PFMT) plus biofeedback vs no treatment, sham treatment or verbal/written instruction General quality of life: > 6 to 12 months · men with urinary incontinence following prostate surgery Conservative interventions for managing urinary incontinence after prostate surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Electrical or magnetic stimulation vs no treatment, sham treatment or verbal/written instruction Subjective cure or improvement: patient‐reported as defined by the trialists, > 6 to 12 months · men with urinary incontinence following prostate surgery Conservative interventions for managing urinary incontinence after prostate surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Electrical or magnetic stimulation vs no treatment, sham treatment or verbal/written instruction Condition‐specific quality of life: using validated questionnaires, > 6 to 12 months · men with urinary incontinence following prostate surgery Conservative interventions for managing urinary incontinence after prostate surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Platinum‐containing chemotherapy vs chemotherapy without platinum Quality of life · early triple‐negative breast cancer Platinum‐based chemotherapy for early triple‐negative breast cancer (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Exercise plus usual pharmacological care vs usual pharmacological care alone Quality of life ‐ not reported · systemic lupus erythematosus Exercise as adjunctive therapy for systemic lupus erythematosus (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Exercise plus usual pharmacological care vs usual pharmacological care alone Serious adverse events ‐ not reported · systemic lupus erythematosus Exercise as adjunctive therapy for systemic lupus erythematosus (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Exercise plus usual pharmacological care vs another intervention (education, joint aids, or relaxation) plus usual pharmacological care Serious adverse events ‐ not reported · systemic lupus erythematosus Exercise as adjunctive therapy for systemic lupus erythematosus (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Exercise plus usual pharmacological care vs another intervention (education, joint aids, or relaxation) plus usual pharmacological care Quality of life ‐ not reported · systemic lupus erythematosus Exercise as adjunctive therapy for systemic lupus erythematosus (2023) · Cochrane | no estimate extracted | NR | No studies |